Watch the full video
Events
Delpharm will manufacture BioNTech/Pfizer’s mRNA vaccine at its Saint-Rémy-sur-Avre site.
GSK agrees to sell its Poznań (Poland) manufacturing site to Delpharm.
A leading CDMO
Drug developer and Contract manufacturer. With its 17 plants, Delpharm is in the Top 5 CDMOs Worldwide.
Dosage forms
Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.
Development & Regulation
A team of experts to support new pharmaceutical products.
100
Management ownership 100%
800
Turnover M€
5
World Top 5
4700
Headcount
Serialization
Major on going project for Delpharm since 2015, all Delpharm plants already shipping serialized products.Read more...
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.Read more...
Soft gel capsules
Delpharm now offers the manufacturing and packaging of soft gel capsules.Freeze-drying
New dosage form now available at Delpharm plants.Customer references
